- Home
- PNC vs ALNY Comparison
PNC vs ALNY Comparison
Compare PNC & ALNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNC
- ALNY
- Stock Information
- Founded
- PNC 1852
- ALNY 2002
- Country
- PNC United States
- ALNY United States
- Employees
- PNC N/A
- ALNY N/A
- Industry
- PNC Major Banks
- ALNY Biotechnology: Pharmaceutical Preparations
- Sector
- PNC Finance
- ALNY Health Care
- Exchange
- PNC Nasdaq
- ALNY Nasdaq
- Market Cap
- PNC 70.4B
- ALNY 60.7B
- IPO Year
- PNC N/A
- ALNY 2004
- Fundamental
- Price
- PNC $182.64
- ALNY $433.17
- Analyst Decision
- PNC Buy
- ALNY Strong Buy
- Analyst Count
- PNC 20
- ALNY 27
- Target Price
- PNC $216.11
- ALNY $476.92
- AVG Volume (30 Days)
- PNC 2.5M
- ALNY 1.2M
- Earning Date
- PNC 10-15-2025
- ALNY 10-30-2025
- Dividend Yield
- PNC 3.72%
- ALNY N/A
- EPS Growth
- PNC 30.88
- ALNY N/A
- EPS
- PNC 15.47
- ALNY 0.33
- Revenue
- PNC $21,799,000,000.00
- ALNY $3,210,070,000.00
- Revenue This Year
- PNC $11.82
- ALNY $60.04
- Revenue Next Year
- PNC $7.53
- ALNY $40.69
- P/E Ratio
- PNC $11.81
- ALNY $1,315.49
- Revenue Growth
- PNC 6.42
- ALNY 53.24
- 52 Week Low
- PNC $145.12
- ALNY $205.87
- 52 Week High
- PNC $216.26
- ALNY $495.55
- Technical
- Relative Strength Index (RSI)
- PNC 40.52
- ALNY 37.69
- Support Level
- PNC $180.03
- ALNY $436.51
- Resistance Level
- PNC $185.09
- ALNY $485.36
- Average True Range (ATR)
- PNC 3.85
- ALNY 18.44
- MACD
- PNC 0.40
- ALNY -4.55
- Stochastic Oscillator
- PNC 55.12
- ALNY 5.38
About PNC PNC Financial Services Group Inc. (The)
PNC Financial is one of the three super-regional banks in the US, with around $560 billion in total assets at the end of June 30, 2025. Headquartered in Pittsburgh, Pennsylvania, PNC Financial has a coast-to-coast branch network, with a strong presence in the US Midwest and Northeast. It is currently expanding in the Southern and Western regions of the US. The bank provides a diversified set of financial services in retail banking, commercial banking, card and treasury management, asset management, and investment banking. PNC derived around 37% of revenue from fee income and 63% from net interest income in 2024.
About ALNY Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.